At total investment of Rs 125 crore
Sharon Bio-Medicine has completed expansion in its 3 manufacturing facilities. The total investment in expansion incurred is to the tune nearly Rs 125 crores. In Dehradun formulation plant, the expanded expenditure has been app. Rs 85 crores where capacity of the plant has been increased more than double. Similarly, other plants' capacity has been added between 30% to 50%. The commercial production in Sharon two expanded plants at Taloja near Navi Mumbai have already been started and Dehradun formulation expanded facility will start production from June 2014.Powered by Capital Market - Live News